Catalogue / Cytoprotection research
BPC-157
Pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, derived from a sequence found in human gastric juice.
Per unit · 1 vial
SKU PSQ-BPC157-5MG
Supply and certificate
Supplied as lyophilised powder in a sealed glass vial, one vial per unit, in 5 mg and 10 mg strengths.
Batch BPC-0426 was analysed by Analiza Białek sp. z o.o. in Wrocław between 13 and 16 April 2026. The report gives a measured content of 5.76 mg for a vial labelled 5 mg, the purity figure, the chromatogram and a photograph of the vial as it was submitted.
The report is reproduced in full on the certificate page, with its lab order number and verification code. The molecular weight above is the free base; acetate and TFA salt forms will not match it.
Specification
| Presentation | Lyophilised powder, sealed glass vial |
|---|---|
| Strength | 5 mg · 10 mg |
| Unit | 1 vial |
| CAS | 137525-51-0 |
| Formula | C62H98N16O22 |
| Molecular weight | 1419.5 g/mol, free base |
| Purity | See report |
| Identity (MS) | See report |
| Certificate | BPC-0426 · issued 16 Apr 2026 · code W1Q63D9A |
Research use
All products are supplied for in-vitro laboratory research only. They are not medicines, not for human or veterinary use, not for food use, and are not offered for the diagnosis, treatment, cure or prevention of any condition. No protocol, quantity or method of administration is supplied with any product. Determining suitability for a given experiment is the researcher’s responsibility. By purchasing you confirm you are a qualified researcher.